Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome

Gloria Peiró(Ludwig-Maximilians-Universität München), Joachim Diebold(Ludwig-Maximilians-Universität München)
Modern Pathology
January 30, 2004
10.1038/modpathol.3800006
Cited by 60

Related Papers

Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
|British Journal of Cancer|2014|94
High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype
|Research Square|2024|1